Column Group Ii, LP is > 10% Shareholder of Oric Pharmaceuticals, Inc.. Currently has a direct ownership of 3.57 Million shares of ORIC, which is worth approximately $35.8 Million. The most recent transaction as insider was on Nov 16, 2021, when has been sold 1,200,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 3.57M
0% 3M change
0% 12M change
Total Value Held $35.8 Million

COLUMN GROUP II, LP Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 16 2021
SELL
Other acquisition or disposition
-
1,200,000 Reduced 25.17%
3,568,181 Common Stock

Also insider at

RCUS
Arcus Biosciences, Inc. Healthcare
RAPT
RAPT Therapeutics, Inc. Healthcare
CGI

Column Group Ii, LP

> 10% Shareholder
San Francisco, CA

Track Institutional and Insider Activities on ORIC

Follow Oric Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ORIC shares.

Notify only if

Insider Trading

Get notified when an Oric Pharmaceuticals, Inc. insider buys or sells ORIC shares.

Notify only if

News

Receive news related to Oric Pharmaceuticals, Inc.

Track Activities on ORIC